{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:57:33Z","timestamp":1794009453029,"version":"4.8.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.psychres.2025.116460","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T19:18:32Z","timestamp":1743189512000},"page":"116460","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Oral versus long-acting injectable antipsychotics in schizophrenia spectrum disorders: A systematic review of patients\u2019 subjective experiences"],"prefix":"10.1016","volume":"348","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-4923-9301","authenticated-orcid":false,"given":"Sofia Francesca","family":"Aprile","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2196-0601","authenticated-orcid":false,"given":"Alessandro","family":"Rodolico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5048-6959","authenticated-orcid":false,"given":"Antonio","family":"Di Francesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Varrasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Bighelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Castellano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Salvina","family":"Signorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Leucht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9867-6054","authenticated-orcid":false,"given":"Filippo","family":"Caraci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2025.116460_bib0001","doi-asserted-by":"crossref","DOI":"10.1186\/s12888-018-1856-y","article-title":"Patient preferences concerning the efficacy and side-effect profile of schizophrenia medications: a survey of patients living with schizophrenia","volume":"18","author":"Achtyes","year":"2018","journal-title":"BMC. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116460_bib0002","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"Association","year":"2022"},{"key":"10.1016\/j.psychres.2025.116460_bib0003","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1017\/S0033291701003749","article-title":"Patients\u2019 and relatives\u2019 assessment of clozapine treatment","volume":"31","author":"Angermeyer","year":"2001","journal-title":"Psychol. Med."},{"key":"10.1016\/j.psychres.2025.116460_bib0004","first-page":"95","article-title":"Drug adherence correlates with attitude towards medication during treatment with antidepressant drugs: a cross-sectional study","volume":"27","author":"Aprile","year":"2024","journal-title":"Life Span. Disabil."},{"key":"10.1016\/j.psychres.2025.116460_bib0005","doi-asserted-by":"crossref","unstructured":"Baldez D.P., Biazus T.B., Rabelo-da-Ponte F.D., Nogaro G.P., Martins D.S., Signori J.P.S., Gnielka V., Passos I.C., Czepielewski L.S., Kunz M. Haloperidol versus second-generation Antipsychotics on the cognitive performance of individuals with schizophrenia and related disorders: pairwise meta-analysis of randomized controlled trials. Trends Psychiatry Psychother. 2023 Jul 25. doi: 10.47626\/2237-6089-2023-0664.","DOI":"10.47626\/2237-6089-2023-0664"},{"key":"10.1016\/j.psychres.2025.116460_bib0006","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1471-2288-9-59","article-title":"Methods for the synthesis of qualitative research: a critical review","volume":"9","author":"Barnett-Page","year":"2009","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.psychres.2025.116460_bib0007","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1080\/09638237.2017.1294735","article-title":"Antipsychotic treatment: experiences of fully recovered service users","volume":"26","author":"Bjornestad","year":"2017","journal-title":"J. Ment. Health"},{"key":"10.1016\/j.psychres.2025.116460_bib0008","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1192\/bjo.2020.4","article-title":"Community perceptions of barriers to management of chronic psychotic disorders and knowledge and attitudes about long-acting injectable antipsychotic medication: qualitative study in Dar es Salaam","volume":"6","author":"Blixen","year":"2020","journal-title":"Tanzania. BJPsych Open"},{"key":"10.1016\/j.psychres.2025.116460_bib0009","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1080\/01612840.2016.1224283","article-title":"Experience of psychotropic medication -an interview study of persons with psychosis","volume":"37","author":"B\u00fclow","year":"2016","journal-title":"Issues Ment. Health Nurs."},{"key":"10.1016\/j.psychres.2025.116460_bib0010","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2147\/PPA.S15337","article-title":"Opinions of French patients with schizophrenia regarding injectable medication","volume":"5","author":"Caroli","year":"2011","journal-title":"Patient Prefer. Adherence"},{"key":"10.1016\/j.psychres.2025.116460_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/frhs.2024.1385398","article-title":"Multi-level barriers and facilitators to implementing evidence-based antipsychotics in the treatment of early-phase schizophrenia","volume":"4","author":"Carroll","year":"2024","journal-title":"Front. Health Serv."},{"key":"10.1016\/j.psychres.2025.116460_bib0012","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1093\/schbul\/sbac041","article-title":"Maintenance treatment with antipsychotic drugs in schizophrenia: a Cochrane Systematic review and Meta-analysis","volume":"48","author":"Ceraso","year":"2022","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2025.116460_bib0013","first-page":"272","article-title":"Qualitative inquiry into motivators for maintaining medication adherence among Taiwanese with schizophrenia","volume":"22","author":"Chang","year":"2013","journal-title":"Int. J. Ment. Health Nurs., Australian & New Zealand Journal of Mental Health Nursing"},{"key":"10.1016\/j.psychres.2025.116460_bib0014","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.2147\/NDT.S206154","article-title":"Patients\u2019 experiences of long-acting injectable antipsychotics: a qualitative study","volume":"15","author":"Chiu","year":"2019","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.psychres.2025.116460_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2023.105454","article-title":"An umbrella review of adverse effects associated with antipsychotic medications: the need for complementary study designs","volume":"155","author":"Chow","year":"2023","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.psychres.2025.116460_bib0016","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.apnu.2020.06.002","article-title":"A qualitative study of medication adherence amongst people with schizophrenia","volume":"34","author":"Clifford","year":"2020","journal-title":"Arch. Psychiatr. Nurs."},{"key":"10.1016\/j.psychres.2025.116460_bib0017","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1176\/ps.49.2.196","article-title":"Compliance with medication regimens for mental and physical disorders","volume":"49","author":"Cramer","year":"1998","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.psychres.2025.116460_bib0018","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12888-022-03822-5","article-title":"An analysis of views about supported reduction or discontinuation of antipsychotic treatment among people with schizophrenia and other psychotic disorders","volume":"22","author":"Crellin","year":"2022","journal-title":"BMC. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116460_bib0020","doi-asserted-by":"crossref","DOI":"10.1186\/s12888-023-04746-4","article-title":"Unmet needs with antipsychotic treatment in schizophrenia and bipolar I disorder: patient perspectives from qualitative focus groups","volume":"23","author":"Doane","year":"2023","journal-title":"BMC. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116460_bib0021","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1590\/0047-2085000000311","article-title":"Patient subjective experience of treatment with long-acting injectable antipsychotics: a systematic review of qualitative studies","volume":"70","author":"Fiore","year":"2021","journal-title":"J. Bras. Psiquiatr."},{"key":"10.1016\/j.psychres.2025.116460_bib0022","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/jpm.12288","article-title":"What is it like to take antipsychotic medication? A qualitative study of patients with first-episode psychosis","volume":"23","author":"Gray","year":"2016","journal-title":"J. Psychiatr. Ment. Health Nurs."},{"key":"10.1016\/j.psychres.2025.116460_bib0023","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1891\/1559-4343.12.1.44","article-title":"The greater of two evils? How people with transformative psychotic experiences view psychotropic medications","volume":"12","author":"Hagen","year":"2010","journal-title":"Ethical Hum. Psychol. Psychiatry Int. J. Crit. Inq., Ethical Human Sciences & Services"},{"key":"10.1016\/j.psychres.2025.116460_bib0024","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S2215-0366(17)30078-0","article-title":"Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis","volume":"4","author":"Hjorth\u00f8j","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.psychres.2025.116460_bib0025","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1365-2850.2012.01898.x","article-title":"Factors influencing the adherence of antipsychotic medication (Aripiprazole) in first-episode psychosis: findings from a grounded theory study","volume":"19","author":"Hon","year":"2012","journal-title":"J. Psychiatr. Ment. Health Nurs."},{"key":"10.1016\/j.psychres.2025.116460_bib0026","doi-asserted-by":"crossref","first-page":"23S","DOI":"10.1177\/088740341305805s04","article-title":"A qualitative study of experiences with and perceptions regarding long-acting injectable antipsychotics: part II-physician perspectives","volume":"58","author":"Iyer","year":"2013","journal-title":"Can. J. Psychiatry Rev. Can. Psychiatr."},{"key":"10.1016\/j.psychres.2025.116460_bib0027","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s12888-019-2304-3","article-title":"Making decisions about antipsychotics: a qualitative study of patient experience and the development of a decision aid","volume":"19","author":"Kaar","year":"2019","journal-title":"BMC. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116460_bib0029","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/bmb\/ldv017","article-title":"Antipsychotic medication in schizophrenia: a review","volume":"114","author":"Lally","year":"2015","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.psychres.2025.116460_bib0030","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/0969733013498528","article-title":"Medication and participation: a qualitative study of patient experiences with antipsychotic drugs","volume":"21","author":"Lorem","year":"2014","journal-title":"Nurs. Ethics"},{"key":"10.1016\/j.psychres.2025.116460_bib0031","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1080\/17542863.2013.783091","article-title":"Poor adherence to antipsychotics amongst schizophrenia patients in Nigeria","volume":"7","author":"Meshach","year":"2014","journal-title":"Int. J. Cult. Ment. Health"},{"key":"10.1016\/j.psychres.2025.116460_bib0032","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/ppc.12444","article-title":"I live, I don't work, but I live a very normal life\u201d-A qualitative interview study of Scandinavian user experiences of schizophrenia, antipsychotic medication, and personal recovery processes","volume":"56","author":"Mollerhoj","year":"2020","journal-title":"Perspect. Psychiatr. Care"},{"key":"10.1016\/j.psychres.2025.116460_bib0033","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1600-0447.2009.01356.x","article-title":"The subjective experience of taking antipsychotic medication: a content analysis of internet data","volume":"120","author":"Moncrieff","year":"2009","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.psychres.2025.116460_bib0034","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1080\/09638237.2017.1370637","article-title":"The least worst option: user experiences of antipsychotic medication and lack of involvement in medication decisions in a UK community sample","volume":"27","author":"Morant","year":"2018","journal-title":"J. Ment. Health"},{"key":"10.1016\/j.psychres.2025.116460_bib0035","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/inm.12110","article-title":"Living with antipsychotic medication side-effects: the experience of Australian mental health consumers","volume":"24","author":"Morrison","year":"2015","journal-title":"Int. J. Ment. Health Nurs."},{"key":"10.1016\/j.psychres.2025.116460_bib0036","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1055\/s-0043-113828","article-title":"Patients\u2019 Knowledge about prescribed antipsychotics and medication adherence in schizophrenia: a cross-sectional survey","volume":"50","author":"Nagai","year":"2017","journal-title":"PharmacoPsychiatry"},{"key":"10.1016\/j.psychres.2025.116460_bib0037","series-title":"Meta-Ethnography: Synthesizing Qualitative Studies","author":"Noblit","year":"1988"},{"key":"10.1016\/j.psychres.2025.116460_bib0038","first-page":"99","article-title":"Antipsychotics side effects\u2019 influence on stigma of mental illness: focus group study results","volume":"21","author":"Novak","year":"2009","journal-title":"Psychiatr. Danub."},{"key":"10.1016\/j.psychres.2025.116460_bib0039","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.psychres.2025.116460_bib0040","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1365-2850.2007.01145.x","article-title":"The subjective experiences of people who regularly receive depot neuroleptic medication in the community","volume":"14","author":"Phillips","year":"2007","journal-title":"J. Psychiatr. Ment. Health Nurs."},{"key":"10.1016\/j.psychres.2025.116460_bib0041","doi-asserted-by":"crossref","DOI":"10.1186\/1471-244X-13-261","article-title":"Patient and prescriber perspectives on long-acting injectable (LAI) antipsychotics and analysis of in-office discussion regarding LAI treatment for schizophrenia","volume":"13","author":"Potkin","year":"2013","journal-title":"BMC. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116460_bib0042","first-page":"65","article-title":"Problems with the administration of antipsychotic drugs in depot formulations in the treatment of schizophrenia","volume":"35","author":"Rankovi\u0107","year":"2018","journal-title":"Acta Fac. Medicae Naissensis"},{"key":"10.1016\/j.psychres.2025.116460_bib0043","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/08039488.2020.1841289","article-title":"Patients\u2019 perspectives on three-monthly administration of antipsychotic treatment with paliperidone palmitate - a qualitative interview study","volume":"75","author":"Rise","year":"2021","journal-title":"Nord. J. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116460_bib0044","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1176\/appi.ps.201900236","article-title":"Focused ethnographic examination of barriers to use of long-acting injectable antipsychotics","volume":"71","author":"Robinson","year":"2020","journal-title":"Psychiatr. Serv. Wash. DC"},{"key":"10.1016\/j.psychres.2025.116460_bib0045","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s40261-024-01391-x","article-title":"Disability and adverse effects of oral versus long-acting injectable antipsychotics in Schizophrenia-spectrum and bipolar disorder: a comparison based on data-driven taxonomy","volume":"44","author":"Rodolico","year":"2024","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.psychres.2025.116460_bib0046","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S2215-0366(21)00437-5","article-title":"Family interventions for relapse prevention in schizophrenia: a systematic review and network meta-analysis","volume":"9","author":"Rodolico","year":"2022","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.psychres.2025.116460_bib0047","doi-asserted-by":"crossref","unstructured":"Rodolico, A., Di Francesco, A., Cutrufelli, P., Bighelli, I., Caponnetto, P., Concerto, C., Conti, D., Furnari, R., Leotta, G., Mineo, L., Messina, A., M\u00fcller, K., Petralia, A., Quattropani, M.C., Siafis, S., Leucht, S., Signorelli, M.S. (2024). Developing STEP-SE: a qualitative usability study of a novel patient-reported outcomes tool for managing side effects in shared decision-making for Schizophrenia Spectrum Disorder care. Health expectations: an international journal of public participation in health care and health policy, 27(6), e70019. https:\/\/doi.org\/10.1111\/hex.70019.","DOI":"10.1111\/hex.70019"},{"key":"10.1016\/j.psychres.2025.116460_bib0048","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.clinthera.2009.07.001","article-title":"Results of a thematic analysis to explore the experiences of patients with schizophrenia taking antipsychotic medication","volume":"31","author":"Rofail","year":"2009","journal-title":"Clin. Ther."},{"key":"10.1016\/j.psychres.2025.116460_bib0049","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S0277-9536(98)00209-3","article-title":"The meaning and management of neuroleptic medication: a study of patients with a diagnosis of schizophrenia","volume":"47","author":"Rogers","year":"1998","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.psychres.2025.116460_bib0050","first-page":"105","article-title":"What is a psychiatric disability? Health Care Anal","volume":"22","author":"Rudnick","year":"2014","journal-title":"HCA J. Health Philos. Policy"},{"key":"10.1016\/j.psychres.2025.116460_bib0051","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci13111577","article-title":"A systematic review on the effectiveness of antipsychotic drugs on the quality of life of patients with schizophrenia","volume":"13","author":"Sampogna","year":"2023","journal-title":"Brain Sci."},{"issue":"1","key":"10.1016\/j.psychres.2025.116460_bib0052","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1186\/s12888-024-06292-z","article-title":"Perspectives of people with schizophrenia on clinical outcome scales and patient-reported outcome measures: a qualitative study","volume":"24","author":"Sawada","year":"2024","journal-title":"BMC. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116460_bib0053","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2024.1377174","article-title":"Using qualitative exit interviews to explore schizophrenia burden and treatment experience in clinical trial patients","volume":"15","author":"Simmons","year":"2024","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116460_bib0054","series-title":"Essential Psychopharmacology of Antipsychotics and Mood Stabilizers","author":"Stahl","year":"2002"},{"issue":"2","key":"10.1016\/j.psychres.2025.116460_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.pec.2009.06.016","article-title":"It\u2019s not my job. I\u2019m the patient not the doctor\u2019: patient perspectives on medicines management in the treatment of schizophrenia","volume":"78","author":"Stewart","year":"2010","journal-title":"Patient Educ. Couns."},{"key":"10.1016\/j.psychres.2025.116460_bib0055","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/wps.20567","article-title":"Management of common adverse effects of antipsychotic medications","volume":"17","author":"Stroup","year":"2018","journal-title":"World Psychiatry"},{"key":"10.1016\/j.psychres.2025.116460_bib0056","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1046\/j.1440-0979.2003.00277.x","article-title":"On the path to recovery: patients\u2019 experiences of treatment with long-acting injections of antipsychotic medication","volume":"12","author":"Svedberg","year":"2003","journal-title":"Int. J. Ment. Health Nurs."},{"key":"10.1016\/j.psychres.2025.116460_bib0057","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/1471-244X-13-168","article-title":"Perspectives on reasons for non-adherence to medication in persons with schizophrenia in Ethiopia: a qualitative study of patients, caregivers and health workers","volume":"13","author":"Teferra","year":"2013","journal-title":"BMC. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116460_bib0058","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2288-8-45","article-title":"Methods for the thematic synthesis of qualitative research in systematic reviews","volume":"8","author":"Thomas","year":"2008","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.psychres.2025.116460_bib0059","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00127-019-01819-2","article-title":"Experiences of taking neuroleptic medication and impacts on symptoms, sense of self and agency: a systematic review and thematic synthesis of qualitative data","volume":"55","author":"Thompson","year":"2020","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"10.1016\/j.psychres.2025.116460_bib0060","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/1471-2288-12-181","article-title":"Enhancing transparency in reporting the synthesis of qualitative research: ENTREQ","volume":"12","author":"Tong","year":"2012","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.psychres.2025.116460_bib0061","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2147\/PPA.S343211","article-title":"Antipsychotic-related stigma and the impact on treatment choices: a systematic review and framework synthesis","volume":"16","author":"Townsend","year":"2022","journal-title":"Patient Prefer. Adherence"},{"key":"10.1016\/j.psychres.2025.116460_bib0062","first-page":"888","article-title":"Becoming adherent to antipsychotics: a qualitative study of treatment-experienced schizophrenia patients. Psychiatr. Serv","volume":"62","author":"Tranulis","year":"2011","journal-title":"Hosp. Community Psychiatry"},{"key":"10.1016\/j.psychres.2025.116460_bib0063","doi-asserted-by":"crossref","first-page":"582","DOI":"10.4103\/IJPSYM.IJPSYM_314_19","article-title":"Biopsychosocial model in Contemporary psychiatry: current validity and future prospects","volume":"41","author":"Tripathi","year":"2019","journal-title":"Indian J. Psychol. Med."},{"key":"10.1016\/j.psychres.2025.116460_bib0064","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1046\/j.1440-0979.2001.00205.x","article-title":"Taking neuroleptic medications as the treatment for schizophrenia: a phenomenological study","volume":"10","author":"Usher","year":"2001","journal-title":"Aust. N. Z. J. Ment. Health Nurs."},{"key":"10.1016\/j.psychres.2025.116460_bib0065","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1590\/0104-1169.3427.2466","article-title":"The meaning of pharmacological treatment for schizophrenic patients","volume":"22","author":"Vedana","year":"2014","journal-title":"Rev. Lat. Am. Enfermagem"},{"issue":"16","key":"10.1016\/j.psychres.2025.116460_bib0066","doi-asserted-by":"crossref","first-page":"7943","DOI":"10.1017\/S0033291723002106","article-title":"Life engagement in people living with schizophrenia: predictors and correlates of patient life engagement in a large sample of people living in the community","volume":"53","author":"Vita","year":"2023","journal-title":"Psychol. Med."},{"issue":"6","key":"10.1016\/j.psychres.2025.116460_bib0067","first-page":"14","article-title":"Reducing the burden of side effects during long-term antipsychotic therapy: the role of \u201cswitching\u201d medications","volume":"68","author":"Weiden","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116460_bib0068","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1600-0447.1992.tb03288.x","article-title":"Treatment with neuroleptics: the patient's perspective","volume":"86","author":"Windgassen","year":"1992","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.psychres.2025.116460_bib0069","doi-asserted-by":"crossref","first-page":"01","DOI":"10.35946\/arcr.v40.3.01","article-title":"What is recovery?","volume":"40","author":"Witkiewitz","year":"2020","journal-title":"Alcohol Res. Curr. Rev."},{"key":"10.1016\/j.psychres.2025.116460_bib0070","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/09638239650036938","article-title":"Clozapine audit: what do patients and relatives think?","volume":"5","author":"Wolfson","year":"1996","journal-title":"J. Ment. Health"},{"key":"10.1016\/j.psychres.2025.116460_bib0071","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/schbul\/sbac001","article-title":"Antipsychotic-induced weight gain: dose-response meta-analysis of randomized controlled trials","volume":"48","author":"Wu","year":"2022","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2025.116460_bib0072","series-title":"Soc Psychiatry Psychiatr Epidemiol","article-title":"Associations between readmission and patient-reported measures in acute psychiatric inpatients: a multicenter prospective longitudinal study","author":"Yamaguchi","year":"2024"},{"key":"10.1016\/j.psychres.2025.116460_bib0073","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/s12888-017-1425-9","article-title":"Experiences of antipsychotic use in patients with early psychosis: a two-year follow-up study","volume":"17","author":"Yeisen","year":"2017","journal-title":"BMC. Psychiatry"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178125001088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178125001088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T04:41:38Z","timestamp":1777956098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178125001088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":72,"alternative-id":["S0165178125001088"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2025.116460","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral versus long-acting injectable antipsychotics in schizophrenia spectrum disorders: A systematic review of patients\u2019 subjective experiences","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2025.116460","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116460"}}